Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000912057-01-510847
Filing Date
2001-04-27
Accepted
2001-04-27 00:00:00
Documents
4
Period of Report
2001-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2046452zdef14a.htm DEF 14A 109101
2 G663671.JPG g663671.jpg GRAPHIC 6329
3 G268444.JPG g268444.jpg GRAPHIC 16845
4 G681751.JPG g681751.jpg GRAPHIC 4907
  Complete submission text file 0000912057-01-510847.txt   139025
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 100 CORPORATE NORTH STE 215 BANNOCKBURN IL 60015 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12493 | Film No.: 1612398
SIC: 2836 Biological Products, (No Diagnostic Substances)